We know where you want to be and how to get you there. Our intricate knowledge of global and local regulatory requirements helps us achieve swift approvals for your products across your target markets.
Our regulatory affairs team is responsible for guiding biologics developers through domestic and international regulatory requirements.
This includes supporting the development of documentation from the preclinical stages to commercialization, SOP streamlining, step-by-step review of data for compliance and regular internal audits.
Our expert team of regulatory professionals brings a wealth of experience and knowledge to your project.
We are a global Continuously Innovative Development and Manufacturing Organization (CIDMO), dedicated to changing the paradigm by which affordable biologic and biosimilar medicines are brought to market. Since Enzene’s inception, our innovative agility has enabled us to continually introduce transformative processes in biologics manufacturing that significantly increase product yields of complex biologics and monoclonal antibodies (mAbs) while reducing the manufacturing footprint and the cost of production.
Game-changing innovation is only the beginning, though. We are Enzene, and that means that our values of innovation, entrepreneurship, respect, candor, excellence, and integrity underscore everything we do from project management and communications to teamwork and ideation. To us, true partnership is about driving biotech innovation while doing so in a way that develops long-lasting trusted partnerships.
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.